LAMEA Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa Arthritic Therapeutic Market would witness market growth of 7.4% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Arthritic Therapeutic Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,461.1 Million by 2030. The Argentina market is showcasing a CAGR of 7.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7% during (2023 - 2030).

Arthritic therapeutics encompass a range of interventions aimed at preserving joint integrity and promoting tissue repair in individuals with degenerative forms of arthritis, such as osteoarthritis. Joint-preserving procedures, including arthroscopy, osteotomy, and cartilage restoration techniques, help address mechanical abnormalities, redistribute load forces, and repair damaged cartilage, thereby delaying joint replacement surgery and prolonging the lifespan of affected joints.

Pain management is a central component of arthritis care, and the therapeutics encompass various modalities to reduce pain and improve functional outcomes. Physical therapy, occupational therapy, and exercise programs help strengthen muscles, improve joint flexibility, and enhance mobility, mitigating pain and improving overall physical function. Assistive devices, such as orthoses, braces, and splints, provide support and stability to arthritic joints, reducing pain and preventing further injury.

Knee osteoarthritis is becoming increasingly prevalent in the LAMEA region due to factors such as population aging, urbanization, sedentary lifestyles, and obesity. With the rising prevalence of knee osteoarthritis, there is a corresponding increase in healthcare spending in the LAMEA region as governments, healthcare systems, and payers allocate resources to address the healthcare needs of individuals with musculoskeletal conditions. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.

Based on Application, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others. Based on Product Type, the market is segmented into Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

AbbVie, Inc.
Pfizer, Inc.
Amgen, Inc.
Novartis AG
F. Hoffmann-La Roche Ltd.
Viatris, Inc.
Bausch Health Companies, Inc.
Sanofi S.A.
Merck & Co., Inc.
Bristol-Myers Squibb Company

LAMEA Arthritic Therapeutic Market Report Segmentation

By Application

Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Others

By Product Type

Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Disease Modified Anti-rheumatoid Drugs (DMARDs)
Biologics
Others

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1LAMEA Arthritic Therapeutic Market, by Application
- 1.4.2LAMEA Arthritic Therapeutic Market, by Product Type
- 1.4.3LAMEA Arthritic Therapeutic Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5.LAMEA Arthritic Therapeutic Market, by Application

5.1LAMEA Rheumatoid Arthritis Market, by Country
5.2LAMEA Psoriatic Arthritis Market, by Country
5.3LAMEA Osteoarthritis Market, by Country
5.4LAMEA Ankylosing Spondylitis Market, by Country
5.5LAMEA Others Market, by Country

Chapter 6.LAMEA Arthritic Therapeutic Market, by Product Type

6.1LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
6.2LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
6.3LAMEA Biologics Market, by Country
6.4LAMEA Others Market, by Country

Chapter 7.LAMEA Arthritic Therapeutic Market, by Country

7.1Brazil Arthritic Therapeutic Market
- 7.1.1Brazil Arthritic Therapeutic Market, by Application
- 7.1.2Brazil Arthritic Therapeutic Market, by Product Type
7.2Argentina Arthritic Therapeutic Market
- 7.2.1Argentina Arthritic Therapeutic Market, by Application
- 7.2.2Argentina Arthritic Therapeutic Market, by Product Type
7.3UAE Arthritic Therapeutic Market
- 7.3.1UAE Arthritic Therapeutic Market, by Application
- 7.3.2UAE Arthritic Therapeutic Market, by Product Type
7.4Saudi Arabia Arthritic Therapeutic Market
- 7.4.1Saudi Arabia Arthritic Therapeutic Market, by Application
- 7.4.2Saudi Arabia Arthritic Therapeutic Market, by Product Type
7.5South Africa Arthritic Therapeutic Market
- 7.5.1South Africa Arthritic Therapeutic Market, by Application
- 7.5.2South Africa Arthritic Therapeutic Market, by Product Type
7.6Nigeria Arthritic Therapeutic Market
- 7.6.1Nigeria Arthritic Therapeutic Market, by Application
- 7.6.2Nigeria Arthritic Therapeutic Market, by Product Type
7.7Rest of LAMEA Arthritic Therapeutic Market
- 7.7.1Rest of LAMEA Arthritic Therapeutic Market, by Application
- 7.7.2Rest of LAMEA Arthritic Therapeutic Market, by Product Type

Chapter 8.Company Profiles

8.1AbbVie, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
8.2Pfizer, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Regional & Segmental Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Acquisition and Mergers:
- 8.2.6SWOT Analysis
8.3Amgen, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Acquisition and Mergers:
- 8.3.6SWOT Analysis
8.4Novartis AG
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expense
- 8.4.5Recent strategies and developments:
  - 8.4.5.1Trials and Approvals:
- 8.4.6SWOT Analysis
8.5F. Hoffmann-La Roche Ltd.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5SWOT Analysis
8.6Viatris, Inc.
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental Analysis
- 8.6.4Research & Development Expense
- 8.6.5Recent strategies and developments:
  - 8.6.5.1Trials and Approvals:
- 8.6.6SWOT Analysis
8.7Bausch Health Companies, Inc
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Sanofi S.A.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5Recent strategies and developments:
  - 8.8.5.1Partnerships, Collaborations, and Agreements:
- 8.8.6SWOT Analysis
8.9Merck & Co., Inc.
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5Recent strategies and developments:
  - 8.9.5.1Partnerships, Collaborations, and Agreements:
- 8.9.6SWOT Analysis
8.10.Bristol-Myers Squibb Company
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

LIST OF TABLES

TABLE 1LAMEA Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2LAMEA Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3LAMEA Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4LAMEA Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5LAMEA Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 6LAMEA Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 7LAMEA Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 8LAMEA Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 9LAMEA Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 10LAMEA Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 11LAMEA Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 12LAMEA Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 13LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 14LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 15LAMEA Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16LAMEA Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 18LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 19LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 20LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 21LAMEA Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 22LAMEA Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 23LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 24LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 25LAMEA Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 26LAMEA Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 27Brazil Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28Brazil Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29Brazil Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30Brazil Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31Brazil Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 32Brazil Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 33Argentina Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 34Argentina Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 35Argentina Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 36Argentina Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 37Argentina Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 38Argentina Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 39UAE Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 40UAE Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 41UAE Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 42UAE Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 43UAE Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 44UAE Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 45Saudi Arabia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 46Saudi Arabia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 47Saudi Arabia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 48Saudi Arabia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 49Saudi Arabia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 50Saudi Arabia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 51South Africa Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 52South Africa Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 53South Africa Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 54South Africa Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 55South Africa Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 56South Africa Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 57Nigeria Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 58Nigeria Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 59Nigeria Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 60Nigeria Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 61Nigeria Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 62Nigeria Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 63Rest of LAMEA Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 64Rest of LAMEA Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 65Rest of LAMEA Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 66Rest of LAMEA Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 67Rest of LAMEA Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 68Rest of LAMEA Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 69Key information - AbbVie, Inc.
TABLE 70Key Information - Pfizer, Inc.
TABLE 71Key Information - Amgen, Inc.
TABLE 72Key Information - Novartis AG
TABLE 73Key Information - F. Hoffmann-La Roche Ltd.
TABLE 74Key Information - Viatris, Inc.
TABLE 75key information - Bausch Health Companies, Inc.
TABLE 76Key Information - Sanofi S.A.
TABLE 77Key Information - Merck & Co., Inc.
TABLE 78Key Information - Bristol-Myers Squibb Company

LAMEA Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents